Literature DB >> 2276414

Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels.

N M Navone1, C F Polo, A L Frisardi, N E Andrade, A M Battle.   

Abstract

1. Porphyrin biosynthesis from delta-aminolevulinic acid (ALA) was investigated using the technique of tissue explant cultures, in both human breast cancer and its original normal tissue. 2. The activity of ALA-dehydratase, porphobilinogenase and uroporphyrinogen decarboxylase was directly determined in both tumor and normal mammary tissues. 3. Porphyrin synthesis capacity of human breast carcinoma was 20-fold enhanced, as compared with normal tissue, at least between the stages of porphobilinogen and coproporphyrinogen formation. 4. The activity of the three enzymes examined was always lower in normal tissue than in tumoral tissue. 5. Present findings show that porphyrin biosynthesis is increased in breast cancer tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276414     DOI: 10.1016/0020-711x(90)90230-z

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  19 in total

1. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2003-12       Impact factor: 1.284

2.  Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes.

Authors:  Stacy R Millon; Julie H Ostrander; Siavash Yazdanfar; J Quincy Brown; Janelle E Bender; Anita Rajeha; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

4.  Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures.

Authors:  A Casas; A M Batlle; A R Butler; D Robertson; E H Brown; A MacRobert; P A Riley
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

5.  Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation.

Authors:  A M Dorward; K S Fancher; T M Duffy; W G Beamer; H Walt
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

6.  Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid.

Authors:  D P Ladner; R A Steiner; J Allemann; U Haller; H Walt
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

7.  Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer.

Authors:  Kishore R Rollakanti; Sanjay Anand; Edward V Maytin
Journal:  Cancer Med       Date:  2015-02-25       Impact factor: 4.452

8.  Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.

Authors:  C S Loh; J Bedwell; A J MacRobert; N Krasner; D Phillips; S G Bown
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

9.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.

Authors:  C Abels; P Heil; M Dellian; G E Kuhnle; R Baumgartner; A E Goetz
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.

Authors:  P Hinnen; F W de Rooij; M L van Velthuysen; A Edixhoven; R van Hillegersberg; H W Tilanus; J H Wilson; P D Siersema
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.